JPS63112694A - Separation and concentration of arachidonic acid and isomyristic acid - Google Patents
Separation and concentration of arachidonic acid and isomyristic acidInfo
- Publication number
- JPS63112694A JPS63112694A JP61256951A JP25695186A JPS63112694A JP S63112694 A JPS63112694 A JP S63112694A JP 61256951 A JP61256951 A JP 61256951A JP 25695186 A JP25695186 A JP 25695186A JP S63112694 A JPS63112694 A JP S63112694A
- Authority
- JP
- Japan
- Prior art keywords
- acid
- arachidonic acid
- isomyristic
- lower alcohol
- arachidonic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 title claims description 106
- YYVJAABUJYRQJO-UHFFFAOYSA-N isomyristic acid Chemical compound CC(C)CCCCCCCCCCC(O)=O YYVJAABUJYRQJO-UHFFFAOYSA-N 0.000 title claims description 62
- 229940114079 arachidonic acid Drugs 0.000 title claims description 53
- 235000021342 arachidonic acid Nutrition 0.000 title claims description 53
- 238000000926 separation method Methods 0.000 title claims 3
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 35
- 150000002632 lipids Chemical class 0.000 claims description 28
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 24
- 239000000194 fatty acid Substances 0.000 claims description 24
- 229930195729 fatty acid Natural products 0.000 claims description 24
- 150000004665 fatty acids Chemical class 0.000 claims description 23
- 239000004202 carbamide Substances 0.000 claims description 20
- -1 alcohol ester Chemical class 0.000 claims description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- 238000000034 method Methods 0.000 claims description 14
- 241001480517 Conidiobolus Species 0.000 claims description 13
- 239000011347 resin Substances 0.000 claims description 13
- 229920005989 resin Polymers 0.000 claims description 13
- 239000002253 acid Substances 0.000 claims description 10
- 238000007259 addition reaction Methods 0.000 claims description 10
- 150000001298 alcohols Chemical class 0.000 claims description 10
- 241000233866 Fungi Species 0.000 claims description 7
- 239000002904 solvent Substances 0.000 claims description 7
- 238000012258 culturing Methods 0.000 claims description 5
- 239000003480 eluent Substances 0.000 claims description 4
- OVARTBFNCCXQKS-UHFFFAOYSA-N propan-2-one;hydrate Chemical compound O.CC(C)=O OVARTBFNCCXQKS-UHFFFAOYSA-N 0.000 claims description 4
- 238000000746 purification Methods 0.000 claims description 4
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 claims description 2
- 235000021360 Myristic acid Nutrition 0.000 claims description 2
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 claims description 2
- 238000006136 alcoholysis reaction Methods 0.000 claims description 2
- 229920001577 copolymer Polymers 0.000 claims 2
- 150000003672 ureas Chemical class 0.000 claims 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 43
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 36
- 210000004027 cell Anatomy 0.000 description 15
- 150000004702 methyl esters Chemical class 0.000 description 15
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 12
- 230000001580 bacterial effect Effects 0.000 description 12
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 10
- 239000002994 raw material Substances 0.000 description 10
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 239000013078 crystal Substances 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- 239000000706 filtrate Substances 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 229910052799 carbon Inorganic materials 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 239000012046 mixed solvent Substances 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- OFIDNKMQBYGNIW-UHFFFAOYSA-N arachidonic acid methyl ester Natural products CCCCCC=CCC=CCC=CCC=CCCCC(=O)OC OFIDNKMQBYGNIW-UHFFFAOYSA-N 0.000 description 3
- OFIDNKMQBYGNIW-ZKWNWVNESA-N methyl arachidonate Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)OC OFIDNKMQBYGNIW-ZKWNWVNESA-N 0.000 description 3
- 150000003904 phospholipids Chemical class 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- JQWAHKMIYCERGA-UHFFFAOYSA-N (2-nonanoyloxy-3-octadeca-9,12-dienoyloxypropoxy)-[2-(trimethylazaniumyl)ethyl]phosphinate Chemical compound CCCCCCCCC(=O)OC(COP([O-])(=O)CC[N+](C)(C)C)COC(=O)CCCCCCCC=CCC=CCCCCC JQWAHKMIYCERGA-UHFFFAOYSA-N 0.000 description 2
- CHRJZRDFSQHIFI-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;styrene Chemical compound C=CC1=CC=CC=C1.C=CC1=CC=CC=C1C=C CHRJZRDFSQHIFI-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000142142 Conidiobolus heterosporus Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 210000000601 blood cell Anatomy 0.000 description 2
- 235000014121 butter Nutrition 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000004817 gas chromatography Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 125000001477 organic nitrogen group Chemical group 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- CASUWPDYGGAUQV-UHFFFAOYSA-M potassium;methanol;hydroxide Chemical compound [OH-].[K+].OC CASUWPDYGGAUQV-UHFFFAOYSA-M 0.000 description 2
- 150000003180 prostaglandins Chemical class 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 238000003828 vacuum filtration Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- ZIIUUSVHCHPIQD-UHFFFAOYSA-N 2,4,6-trimethyl-N-[3-(trifluoromethyl)phenyl]benzenesulfonamide Chemical compound CC1=CC(C)=CC(C)=C1S(=O)(=O)NC1=CC=CC(C(F)(F)F)=C1 ZIIUUSVHCHPIQD-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241001468211 Conidiobolus sp. Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- NHTMVDHEPJAVLT-UHFFFAOYSA-N Isooctane Chemical compound CC(C)CC(C)(C)C NHTMVDHEPJAVLT-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 102000015439 Phospholipases Human genes 0.000 description 1
- 108010064785 Phospholipases Proteins 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 235000010724 Wisteria floribunda Nutrition 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- JVSWJIKNEAIKJW-UHFFFAOYSA-N dimethyl-hexane Natural products CCCCCC(C)C JVSWJIKNEAIKJW-UHFFFAOYSA-N 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- DKAGJZJALZXOOV-UHFFFAOYSA-N hydrate;hydrochloride Chemical compound O.Cl DKAGJZJALZXOOV-UHFFFAOYSA-N 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 125000005395 methacrylic acid group Chemical group 0.000 description 1
- YEYZNBKNDWPFSQ-UHFFFAOYSA-N methanol;urea Chemical compound OC.NC(N)=O YEYZNBKNDWPFSQ-UHFFFAOYSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 238000011218 seed culture Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- IFLREYGFSNHWGE-UHFFFAOYSA-N tetracene Chemical compound C1=CC=CC2=CC3=CC4=CC=CC=C4C=C3C=C21 IFLREYGFSNHWGE-UHFFFAOYSA-N 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Fats And Perfumes (AREA)
Abstract
(57)【要約】本公報は電子出願前の出願データであるた
め要約のデータは記録されません。(57) [Abstract] This bulletin contains application data before electronic filing, so abstract data is not recorded.
Description
【発明の詳細な説明】
(産業上の利用分野)
本発明は、コニディオボラスa (Conidiobo
lussp、)糸状菌を培養して得られる脂質からアラ
キドン酸、イソミリスチン酸又はそれらの低級アルコー
ルエステルを分離し濃縮する方法に関する。DETAILED DESCRIPTION OF THE INVENTION (Field of Industrial Application) The present invention relates to the use of Conidiobolus a (Conidiobolus a).
The present invention relates to a method for separating and concentrating arachidonic acid, isomyristic acid, or lower alcohol esters thereof from lipids obtained by culturing filamentous fungi.
(従来の技術)
アラキドン酸は現在、最重要な生理活性物質の一つであ
るプロスタグランジンの前駆体物質としてよく知られて
おり、生体内ではリン脂質の形で蓄積されている。この
リン脂質は細胞膜などの生体膜の重要な構成成分であり
、アラキドン酸は生体の必要に応じ、あるいは何らかの
刺激を受けるとホスホリパーゼの作用でリン脂質から切
り出され、プロスタグランジンへ変換され、各種の生理
機能を発揮する。従って、アラキドン酸は生体にとって
非常に重要な高度不飽和脂肪酸である。(Prior Art) Arachidonic acid is currently well known as a precursor substance of prostaglandin, which is one of the most important physiologically active substances, and is accumulated in the body in the form of phospholipids. This phospholipid is an important component of biological membranes such as cell membranes, and arachidonic acid is excised from the phospholipid by the action of phospholipase and converted to prostaglandin in response to the needs of the living body or when it receives some stimulus. exert physiological functions. Therefore, arachidonic acid is a highly unsaturated fatty acid that is extremely important for living organisms.
また、イソミリスチン酸はミリスチン酸よりも融点が低
く、安定性の高い飽和脂肪酸で、生物の脂質に少量見出
され、化粧品等としての利用が期待される脂肪酸である
。In addition, isomyristic acid is a highly stable saturated fatty acid with a lower melting point than myristic acid, and is found in small amounts in the lipids of living organisms, and is a fatty acid that is expected to be used in cosmetics and the like.
アラキドン酸およびミリスチン酸は重要な脂質であり、
その利用も医薬、試薬、健康食品等として、いろいろ考
えられ、その工業的展開が期待されている。Arachidonic acid and myristic acid are important lipids;
Various uses for it are being considered, such as medicines, reagents, health foods, etc., and its industrial development is expected.
(発明が解決しようとする問題点)
しかしながら、いずれの用途においても現在のところ、
化学合成が掻めて困難なため、原料は天り(;′1勿か
ら得られている。(Problems to be solved by the invention) However, in any application, at present,
Because chemical synthesis is difficult, the raw material is obtained from Tenri (;'1).
”アラキドン酸は、その原料が非常に特殊な原料、例え
ば哺乳動物の肝臓、腎臓、心臓、血液、あるいは魚類の
肝臓であり、工業的に応用するには至っていない。現在
、工業的に応用できると思われるものは、卵黄レシチン
から得られるアラキドン酸であるが、これもその他の脂
肪酸11が多いため、分取にかなりの技術を要する。``Arachidonic acid is made from very special raw materials, such as mammalian liver, kidney, heart, blood, or fish liver, and has not yet been applied industrially.Currently, it cannot be applied industrially. What is thought to be arachidonic acid is obtained from egg yolk lecithin, but since this also contains a large amount of other fatty acids 11, it requires considerable skill to separate.
又、イソミリスチン酸は従来、バターのような脂質中に
少量しか含まれていないもので、工業的に得るには困難
であった。Furthermore, isomyristic acid has conventionally been contained in only a small amount in fats such as butter, and it has been difficult to obtain it industrially.
工業的に応用するのが困難な理由として、エム・ケーラ
(M、 Kates著、山川ら訳、脂質研究法、65頁
、1975、東京化学同人)が示すように、高度不飽和
酸を含有する動物組織、細胞画分、血球および血美から
の脂質抽出が非常に?=kffiな規模で行われる場合
にも、繁雑な工程を要するからである。The reason why it is difficult to apply it industrially is that it contains highly unsaturated acids, as shown by M. Kates, translated by Yamakawa et al., Lipid Research Methods, p. 65, 1975, Tokyo Kagaku Dojin. Lipid extraction from animal tissues, cell fractions, blood cells and blood cells is very? This is because, even when carried out on a scale of =kffi, complicated steps are required.
そして得られた脂質からアラキドン酸を単gffするの
も各種の高度不飽和酸が混在するために、操作が繁雑で
あり、アラキドン酸の二重結合の移動やポリマー化のた
めに蒸留が困難である。それに加えて含有アラキドン酸
■が多(ないという問題点と、卵黄レシチンを除くその
他の天然原料は保存、輸送等に多くの費用がかかるとい
う欠点があった。The simple gff process of arachidonic acid from the obtained lipid is complicated due to the presence of various highly unsaturated acids, and the movement of the double bonds and polymerization of arachidonic acid makes distillation difficult. be. In addition, there was the problem that it contained a large amount of arachidonic acid (2), and the other natural raw materials except egg yolk lecithin had the disadvantage that it required a lot of cost to store, transport, etc.
イソミリスチン酸は、上述のように天然にはバター中に
少量しか含まれていないため、その物性が良く、安定で
融点が低い特徴から、化粧品基材、石鹸、界面活性剤な
どに用いることが可能であるにもかかわらず、その工業
的展開が全く図られていない。As mentioned above, isomyristic acid is naturally contained in only a small amount in butter, and because of its good physical properties, stability, and low melting point, it can be used in cosmetic base materials, soaps, surfactants, etc. Although it is possible, no attempt has been made to develop it industrially.
(問題点を解決するための手段)
本発明は上記問題点を解決するためのもので、工業的応
用として微生物を利用し、安価で入手しやすい原料から
簡単な操作によってアラキドン酸およびイソミリスチン
酸を分離濃縮する方法を提供することを目的としている
。(Means for Solving the Problems) The present invention is intended to solve the above problems, and uses microorganisms for industrial application to produce arachidonic acid and isomyristic acid from inexpensive and easily available raw materials by simple operations. The purpose is to provide a method for separating and concentrating.
本発明は、コニディオボラス属(効ユ1diobolu
sSρ、)糸状菌を培養して得られる脂質を加水分解又
は低級アルコールとアルコーリシスし、得られた脂IJ
j酸又はその低級アルコールエステルからアラキドン酸
、イソミリスチン酸又はそれらの低級アルコールエステ
ルを尿素付加反応および非極性多孔性樹脂による精製に
より分離濃縮することを特徴とする。The present invention relates to the genus Conidiobolus
sSρ,) Lipids obtained by culturing filamentous fungi are hydrolyzed or alcoholysed with lower alcohols, resulting in lipid IJ
This method is characterized by separating and concentrating arachidonic acid, isomyristic acid, or lower alcohol esters thereof from j-acid or lower alcohol ester thereof by urea addition reaction and purification using a non-polar porous resin.
本発明に使用するコニディオボラス属
(Con1diobolus sp、)糸状菌は、すで
にアラキドン酸を蓄積することが知られている〔カナデ
ィアン・ジャーナル・オブ・マイクロバイオ口ジイ(C
anadian Journal of Microb
iology 13. 755(1967)、同1
7. 1115 (1971) 、同22. 105
8 (1976) 、ジャーナル・オブ・アプライド
・バタテリオロジイ(Journal of Appl
ied Bacteriology 54+ 85(
1983) )。しかし、これらの論文に示されたもの
はすべて分析を主としたもので、苗の特徴を示すもので
しかない。The filamentous fungi of the genus Conidiobolus used in the present invention are already known to accumulate arachidonic acid [Canadian Journal of Microbiology (C.
anadian journal of microb
iology 13. 755 (1967), same 1
7. 1115 (1971), 22. 105
8 (1976), Journal of Applied Batteriology
ied Bacteriology 54+ 85(
1983) ). However, all of the information presented in these papers is based on analysis and only shows the characteristics of seedlings.
本発明者らは、先にコニディオボラス屈(Con1di
obolus sp、)糸状菌を有機体窒素と炭水化物
を基質として培養したときに、菌体内脂質が乾燥菌体中
に30〜50%蓄積し、脂質脂肪酸中のアラキドン酸が
25〜40%に達することを見出した。The present inventors previously reported that Conidiobolus
When filamentous fungi (Obolus sp.) are cultured using organic nitrogen and carbohydrates as substrates, intracellular lipids accumulate in the dried bacterial cells by 30-50%, and arachidonic acid in the lipid fatty acids reaches 25-40%. I found out.
そのときのイソミリスチン酸は25〜40%を占めてい
た。アラキドン酸の含有値は上記論文にあるどの値より
も高いものであった。At that time, isomyristic acid accounted for 25-40%. The content value of arachidonic acid was higher than any value in the above paper.
本発明はこのアラキドン酸およびイソミリスチン酸含有
菌を使用したものである。前記培養液から濾過等によっ
て取り出された菌体を溶剤抽出し、得られた脂質を加水
分解又は低級アルコールとアルコーリシスした後、尿素
付加反応させると、イソミリスチン酸またはその低級ア
ルコールエステルの尿素付加物が得られ、効率よ(アラ
キドン酸とイソミリスチン酸が分離できる。次いで、ス
チレン−ジビニルベンゼン樹脂のような非極性多孔性樹
脂をカラムにつめ、アセトン−水系又は低級アルコール
−水系等の溶出剤を用いて非尿素付加物を溶出すること
により、アラキドン酸又はその低級アルコールエステル
が純度よく精製される。The present invention uses this arachidonic acid- and isomyristic acid-containing bacterium. The bacterial cells removed from the culture solution by filtration or the like are extracted with a solvent, the obtained lipids are hydrolyzed or alcoholized with a lower alcohol, and then subjected to a urea addition reaction, resulting in urea addition of isomyristic acid or its lower alcohol ester. The product can be obtained efficiently (arachidonic acid and isomyristic acid can be separated).Next, a non-polar porous resin such as styrene-divinylbenzene resin is packed in a column, and an eluent such as an acetone-water system or a lower alcohol-water system is used. Arachidonic acid or its lower alcohol ester is purified to a high degree of purity by eluting the non-urea adduct using
この場合、アクリル系、メタクリル系多孔性樹脂、ある
いはシリカゲル、シリカゲル誘導体等を用いても精製で
きるが、処理能力が少し低い。In this case, purification can be achieved using acrylic or methacrylic porous resins, silica gel, silica gel derivatives, etc., but the throughput is a little low.
本発明における原料である脂質はコニディオボラス属(
Conidiobolus sp、)の糸状菌を培養し
て得られる菌体を溶剤抽出して得られるものであるが、
この菌体としては、コニディオボラス・ヘテロスポラス
(Conidiobolus 1leLeros o
rus) 、コニディオボラス・ランプロウゲス (C
onidiobolusLam川I至) 、コニディオ
ボラス用オイリミクス(Con1dfobolus
ム■虹旦註、コニディオボラス・種があげられる。The lipid that is the raw material in the present invention is of the genus Conidiobolus (
It is obtained by solvent extraction of the cells obtained by culturing filamentous fungi of Conidiobolus sp.
This bacterial cell is Conidiobolus heterosporus (Conidiobolus 1leLeroso).
rus), Conidioborus lamprouges (C
onidiobolus (Lamkawa I), Conidiobolus eurymicus (Con1dfobolus)
Conidiobolus species can be mentioned.
培養はグルコース、マルトエキストラクト、蔗糖、糖蜜
、コーンステイープリカー、フラクトース、澱粉等を炭
素源とし、窒素源としてペプトン、肉エキス、酵母エキ
ス、大豆粉等の有機体窒素を用い、その地鉄、マグネシ
ウム、リン酸、カリウム等の無機物質および必要に応じ
てビタミン等の1故璧要素を加えた培地で行う。The culture uses glucose, malt extract, sucrose, molasses, cornstap liquor, fructose, starch, etc. as a carbon source, and organic nitrogen such as peptone, meat extract, yeast extract, soy flour, etc. as a nitrogen source. It is carried out in a medium containing inorganic substances such as , magnesium, phosphoric acid, potassium, etc. and, if necessary, primary elements such as vitamins.
p Hは4〜7の微酸性でよ(、通常は振盪培養等の通
気液体培養で培養する。培養日数は2〜7日でよく、培
養終了後、遠心分^11又は減圧濾過により菌体を取り
出す。この菌体にはアラキドン酸、イソミリスチン酸が
多量に含まれているので、できるだけ酸素にふれない様
に抽出することが必要であるが、菌体は特に乾燥させる
必要はない。The pH should be slightly acidic, with a pH of 4 to 7. (Usually, culture is carried out using aerated liquid culture such as shaking culture. The number of culture days may be 2 to 7 days. After the culture is completed, the bacterial cells are removed by centrifugation^11 or vacuum filtration. Since this bacterial cell contains a large amount of arachidonic acid and isomyristic acid, it is necessary to extract it while avoiding exposure to oxygen as much as possible, but there is no need to dry the bacterial cell.
抽出はメタノール、エタノール、プロパツール、イソプ
ロパツール等の低級アルコール、アセトン、メチルエチ
ルケトン、クロロホルム等が好ましいが、ヘキサン、石
油エーテル、石油ベンジン、エーテル、ベンゼン等を加
えて用いてもよい。これら溶剤を単一又は混合し、菌体
に加え、攪拌しつつ脂質を抽出し、菌体を濾過する。こ
れを数回繰り返し、完全に脂質を抽出する。抽出液を全
部集めン]縮し、原料脂質とする。For extraction, lower alcohols such as methanol, ethanol, propatool, isopropanol, acetone, methyl ethyl ketone, chloroform, etc. are preferable, but hexane, petroleum ether, petroleum benzine, ether, benzene, etc. may be used in addition. These solvents are added alone or in combination to the bacterial cells, the lipids are extracted while stirring, and the bacterial cells are filtered. Repeat this several times to completely extract the lipids. All the extracts are collected and condensed to obtain the raw material lipid.
原料脂質をメタノール、エタノール、プロパツール等の
低級アルコールに溶解し、水酸化ナトリウム又は水酸化
カリウム等で常法通すケン化し、塩酸等で酸に戻し、脂
肪酸を得るか、又は原料脂質をメタノール、エタノール
、プロパツール等の1氏11反アルコール
水酸化カリウム等を触媒として20〜60’Cでアルコ
ーリシスし、脂肪酸低級アルコーリシステルヲfする。The raw material lipid is dissolved in a lower alcohol such as methanol, ethanol, propatool, etc., saponified by a conventional method with sodium hydroxide or potassium hydroxide, etc., and returned to acid with hydrochloric acid etc. to obtain a fatty acid, or the raw material lipid is dissolved in methanol, Alcoholysis is carried out at 20 to 60'C using potassium hydroxide, etc., as a catalyst, to form fatty acid lower alcoholysters.
脂肪酸又は脂肪酸低級アルコールエステルは、各々ヘキ
サン等で抽出、水洗を行い、脱溶剤し、精製する。The fatty acid or fatty acid lower alcohol ester is extracted with hexane or the like, washed with water, solvent removed, and purified.
尿素付加反応は、脂肪酸又は脂肪酸低級アルコールエス
テルを、その各々の1〜8倍量の尿素を含んだメタノー
ル−尿素飽10溶液に加えて、攪拌しつつ冷却し、付加
体の結晶を析出させることによって行われる。この結晶
を濾別し、濾液と結晶に分離する。In the urea addition reaction, fatty acids or fatty acid lower alcohol esters are added to a methanol-urea saturated 10 solution containing 1 to 8 times the amount of urea, and the mixture is cooled with stirring to precipitate crystals of the adduct. carried out by The crystals are filtered and separated into a filtrate and crystals.
分離した濾液を濃縮し、塩酸水溶液を加え、ヘキサンで
抽出、水洗すると、アラキドン酸を多く含む脂肪酸又は
脂肪酸低級アルコールエステルが得られる。The separated filtrate is concentrated, added with aqueous hydrochloric acid, extracted with hexane, and washed with water to obtain a fatty acid or fatty acid lower alcohol ester containing a large amount of arachidonic acid.
又、分離した付加体の結晶を塩酸水溶液で溶解し、ヘキ
サンで抽出、水洗し、イソミリスチン酸を多く含む脂肪
酸又は脂肪酸低級アルコールエステルを得ろことができ
る。その際、ヘキサンで抽出、次いで水洗した後、脂肪
酸の場合はヘキサン中で0〜5°Cで再結晶することに
より、イソミリスチン酸を90%以上に濃縮でき、脂肪
酸低級アルコールエステルの場合は減圧下積留すること
により、イソミリスチン酸低級アルコールエステルを9
0%以上に濃縮できる。低級アルコールエステルの場合
は再結晶と精密を組み合わせてもよい。Alternatively, a fatty acid or fatty acid lower alcohol ester containing a large amount of isomyristic acid can be obtained by dissolving the separated adduct crystals in an aqueous hydrochloric acid solution, extracting with hexane, and washing with water. At that time, isomyristic acid can be concentrated to over 90% by extracting with hexane, then washing with water, and recrystallizing in hexane at 0 to 5°C in the case of fatty acids, and reduced pressure in the case of fatty acid lower alcohol esters. By distilling the isomyristic acid lower alcohol ester, 9
Can be concentrated to 0% or more. In the case of lower alcohol esters, recrystallization and precision may be combined.
なお、使用尿素量は脂質量、処理温度、メタノール量に
よって異なるが、好ましくは脂質量の2〜4倍である。The amount of urea used varies depending on the amount of lipid, treatment temperature, and amount of methanol, but is preferably 2 to 4 times the amount of lipid.
又、付加反応は50〜60℃の尿素飽和メタノール溶液
に原料脂質を加え、5〜10℃まで徐冷して反応させる
のが好ましく、そのときのメタノール量は、濾過操作等
を考慮すると、脂質量の10〜20倍量が好ましい。In the addition reaction, it is preferable to add the raw material lipid to a urea-saturated methanol solution at 50 to 60°C and slowly cool it to 5 to 10°C to react.The amount of methanol at this time is determined based on the amount of lipid The amount is preferably 10 to 20 times the amount.
又、尿素付加反応は尿素をヘキサン、イソオクタン等に
懸濁し、少量のメタノールを触媒的に用いろ固相尿素付
加反応でも行うことができる。The urea addition reaction can also be carried out by suspending urea in hexane, isooctane, etc. and using a small amount of methanol as a catalyst.
次いで、尿素付加反応により粗精製されたアラキドン酸
を多く含む脂肪酸、又はアラキドン酸低級アルコールエ
ステルを多く含む脂肪酸低級アルコールエステルを、非
極性多孔性樹脂の入ったカラムで、アセトン−水又は低
級アルコール−水等を溶出剤として精製する。例えば、
スチレン−ジビニルベンゼン樹脂(HP−20、三菱化
成製)500 mlをカラムにつめ、尿素付加後の粗精
製アラキドン酸低級アルコールエステル10gをカラム
上部に吸着させ、次いでアセトン/水=80/20(v
/v)の溶出液を流すことにより、アラキドン酸又はア
ラキドン酸低級アルコールエステルをガスクロマトグラ
フィー等でチェックしつつ精製することができる。Next, a fatty acid containing a large amount of arachidonic acid or a fatty acid lower alcohol ester containing a large amount of arachidonic acid lower alcohol ester, crudely purified by urea addition reaction, is treated with acetone-water or lower alcohol-containing column in a column containing a non-polar porous resin. Purify using water etc. as an eluent. for example,
Fill a column with 500 ml of styrene-divinylbenzene resin (HP-20, manufactured by Mitsubishi Kasei), adsorb 10 g of crude arachidonic acid lower alcohol ester after addition of urea to the top of the column, and then add acetone/water = 80/20 (v
By flowing the eluate of /v), arachidonic acid or arachidonic acid lower alcohol ester can be purified while being checked by gas chromatography or the like.
以上の操作の結果、アラキドン酸又はアラキドン酸低級
アルコールエステルは尿素付加で70〜80%に濃縮で
き、樹脂カラムで95〜99%にまで濃縮できる。As a result of the above operations, arachidonic acid or arachidonic acid lower alcohol ester can be concentrated to 70 to 80% by addition of urea, and can be concentrated to 95 to 99% by using a resin column.
(発明の効果)
本発明によれば、大量生産のできる微生物菌体よりアラ
キドン酸、イソミリスチン酸又はそれらの低級アルコー
ルエステルを簡単な方法で得ることができるので、医薬
品、健康食品、化粧品などの原料として、安価に効果的
に用いることができる。(Effects of the Invention) According to the present invention, arachidonic acid, isomyristic acid, or their lower alcohol esters can be obtained by a simple method from microbial cells that can be mass-produced. It can be used effectively and inexpensively as a raw material.
(実施例) 以下実施例に基づいて本発明を具体的に説明する。(Example) The present invention will be specifically described below based on Examples.
実施例1
グルコース30g1マルトエキス30g、イーストエキ
ス12g1硫酸第一鉄0.7g、硫酸マグネシウム 0
.5g、リン酸水素二カリウム1g、塩化カリウム0.
5gを11の水道水に溶解したものを、培地とした。こ
の培地をIOMづつ500mx容の広口ごlルベン5木
にとり、120°C115分オートクレーブで殺菌した
。培地のp Hは5.6であった。Example 1 Glucose 30g 1 malt extract 30g, yeast extract 12g 1 ferrous sulfate 0.7g, magnesium sulfate 0
.. 5g, dipotassium hydrogen phosphate 1g, potassium chloride 0.
A culture medium was prepared by dissolving 5 g in 11 tap water. This medium was placed in a 500 m x wide-mouth Rubene 5 x IOM and sterilized in an autoclave at 120°C for 115 minutes. The pH of the medium was 5.6.
ごこに、ポテト寒天培地で培養しておいたコニディオボ
ラス・ヘテロスポラス(Conidiobolus販(
肛」上m巨)訂CC12941の胞子を殺菌水で)へ;
罰して植菌した。28℃、130rpmで3日間振とう
培養したものを菌種として使用し、30I!のジャーフ
ァメンターで本培養した。Here, Conidiobolus heterosporus (Conidiobolus) cultured on potato agar medium
Remove the spores of CC12941 with sterile water);
I was punished and inoculated. A strain cultured at 28°C with shaking at 130 rpm for 3 days was used as the bacterial strain, and 30I! Main culture was carried out in a jar fermenter.
本培養は以下のようにして行った。The main culture was performed as follows.
すなわち、種培養で用いたものと同一組成の培地201
を306容のジャーファメンターに仕込み、藤気殺菌し
た後、上記種菌5木を植菌し、5日間’E’iaした。In other words, the medium 201 has the same composition as that used in the seed culture.
The seeds were placed in a 306-volume jar fermenter, sterilized with Fuji air, and the above-mentioned 5 seeds were inoculated and allowed to 'E'ia for 5 days.
攪拌羽はタービン式のものを用い、温度28℃、通気量
IVVM、回転数500rpmで培養した。A turbine-type stirring blade was used, and the culture was carried out at a temperature of 28° C., an aeration amount of IVVM, and a rotation speed of 500 rpm.
培養5日間で培養を終え、菌体を波圧;慮過した。The culture was completed after 5 days, and the bacterial cells were removed under wave pressure.
このときの乾燥菌体量は35g/ (lであった。The amount of dry bacterial cells at this time was 35 g/(l).
減圧濾過後の菌体を湿閏体のままクロロホルム/メタノ
ール=2/1の混合溶媒57!につけ、攪拌機で2時間
(1゛l拌した。抽出液を濾別し、残渣を31の同溶剤
で同様に抽出し、2回繰り返した。After vacuum filtration, the bacterial cells remain as wet cells in a mixed solvent of chloroform/methanol = 2/1 57! The mixture was soaked in water and stirred with a stirrer for 2 hours (1 l). The extract was filtered, and the residue was extracted in the same manner as in step 31, and the procedure was repeated twice.
抽出液を合わせて、フォルテ(Folch)の方法で水
溶性物質を除き、クロロホルム層を濃縮し、総脂質を得
た。The extracts were combined, water-soluble substances were removed by Folch's method, and the chloroform layer was concentrated to obtain total lipids.
この脂質はTLC(展開剤:クロロホルム/メタノール
/水=65/25/ 4 )でほとんどが中性脂質であ
り、そのほとんどはトリグリセリドであり、極性脂質は
少なかった。酸価は3.6であった。得られた総脂質量
は245gであった。Most of these lipids were found to be neutral lipids by TLC (developing agent: chloroform/methanol/water = 65/25/4), most of which were triglycerides, and there were few polar lipids. The acid value was 3.6. The total amount of lipid obtained was 245 g.
この245gの総脂質をメタノール21に溶解し、10
0m1のメタノールに溶解した水酸化カリウム3gを加
え、50°Cで2時間メタツリシスした。反応終了後、
酢酸により水酸化カリウムを中和し、次いでエバボレー
トし、メタノールを除いた。得られたメチルエステルに
ヘキサンを50M加え、水洗した。ヘキサンをエバボレ
ートしてメチルエステル225gを得た。このメチルエ
ステルの組成は次のようであった。Dissolve 245 g of total lipids in 21 methanol and 10
3 g of potassium hydroxide dissolved in 0 ml of methanol was added and metathurisis was carried out at 50° C. for 2 hours. After the reaction is complete,
Potassium hydroxide was neutralized with acetic acid and then evaporated to remove methanol. 50M hexane was added to the obtained methyl ester, and the mixture was washed with water. Hexane was evaporated to obtain 225 g of methyl ester. The composition of this methyl ester was as follows.
イソC14,。;29.6%、C1416; 5.1
%、イソC+S+。; 10.1%、C13,。;3.
6%、C16,。;8.7 %、C+s+o; 2
.0%、C18++; 3.3%、CI11+2 ;
2.2%−Cl11+3 i 1.2%% C
zo+ti o、ft%、アラキドン酸;32.5%
、その他1.3%尿素675gを50°Cでメタノール
3.57!に?8止し、そこにメチルエステル225g
を加えた。攪拌しながら徐々に冷却し、20℃まで冷却
した。析出した1111品を濾別し、濾液からエバボレ
ートしてメタノール11を除いた。このとき結晶側にほ
とんどの飽和酸とC,8,、酸および一部のイソ酸が付
加された。濃縮濾液をj辺拌しながら10℃まで徐冷し
、析出した結晶を濾別した。次いで′61.液に塩酸酸
性水を加え、ヘキサンで抽出し、83.6gのメチルエ
ステルを得た。IsoC14,. ;29.6%, C1416; 5.1
%, isoC+S+. ; 10.1%, C13. ;3.
6%, C16. ;8.7%, C+s+o; 2
.. 0%, C18++; 3.3%, CI11+2;
2.2%-Cl11+3 i 1.2%% C
zo+ti o, ft%, arachidonic acid; 32.5%
, other 1.3% urea 675g at 50°C methanol 3.57! To? 8, and add 225g of methyl ester there.
added. The mixture was gradually cooled to 20° C. while stirring. The precipitated product 1111 was separated by filtration, and the filtrate was evaporated to remove methanol 11. At this time, most of the saturated acid, C, 8, acid, and some isoacids were added to the crystal side. The concentrated filtrate was slowly cooled to 10° C. while stirring, and the precipitated crystals were filtered off. Then '61. Hydrochloric acid acidic water was added to the liquid, and the mixture was extracted with hexane to obtain 83.6 g of methyl ester.
この組成は、イソC44,。(イソミリスチン酸);5
.5%、イア C15:o ; 4.5%、Cr、z
y: 3.79叙Czo++ ;1.0%、アラキド
ンu ; 74.9%、その池10.4%であった。This composition is isoC44. (isomyristic acid); 5
.. 5%, Ia C15:o; 4.5%, Cr, z
y: 3.79% Czo++; 1.0%, Arachidon u; 74.9%, and 10.4%.
又、結晶側を塩酸酸性水溶液で分解し、ヘキサン抽出し
て47.9gのメチルエステルを得た。この3且或は、
イソC+aro (イソミリスチン酸) i64.2
%、イソC+s+o ; 25.1%、Cl11+□;
2.4%、アラキドン酸:3.5%、その他4.7%で
あった。Further, the crystal side was decomposed with an acidic aqueous solution of hydrochloric acid and extracted with hexane to obtain 47.9 g of methyl ester. These three or
IsoC+aro (isomyristic acid) i64.2
%, isoC+s+o; 25.1%, Cl11+□;
2.4%, arachidonic acid: 3.5%, and others 4.7%.
次いで74.9%のアラキドン酸を含むメチルエステル
83.6gを、)lr’−20(三菱化成製)4Jの入
った内径I Q cmのカラム上部に吸着させた。カラ
ム上部よりアセトン/水−8/2の混合溶剤を通過させ
、カラム下部よりアラキドン酸含量をガスクロマトグラ
フィーでモニターしながら分取した。アラキドン酸含1
98%以上のものを集め、?農縮し、アラキドン酸メチ
ルエステル99%含有品45.7gを得た。Then, 83.6 g of methyl ester containing 74.9% arachidonic acid was adsorbed onto the upper part of a column containing 4J of )lr'-20 (manufactured by Mitsubishi Kasei) and having an inner diameter of I Q cm. A mixed solvent of acetone/water (8/2) was passed through the upper part of the column, and the arachidonic acid content was collected from the lower part of the column while being monitored by gas chromatography. Contains arachidonic acid 1
Collect over 98% of things? Agricultural shrinkage was performed to obtain 45.7 g of a product containing 99% arachidonic acid methyl ester.
次いで99%アラキドン酸メチルエステルを水酸化カリ
ウム−メタノール溶液で加水分解し、99ン6アラキド
ン酸メチルエステルを39.9g得た。Next, 99% arachidonic acid methyl ester was hydrolyzed with a potassium hydroxide-methanol solution to obtain 39.9 g of 99-6 arachidonic acid methyl ester.
実施例2
実施例1と同様にして得た聡脂!245gを含水メタノ
ール−水酸化カリウム溶液で常法通り加水分解し、塩酸
水により脂肪酸に戻し、ヘキサンで抽出し、脂肪酸混合
物1913 g;t−得た。実施例1と同様に尿素付加
反応を行い、濾液側よりイソC1410(イソミリスチ
ンiり ; 6.1%、イソC13,。;4.3
%、C+a+s ; 3.5%、C2゜+:+i
1.0%、アラキドン酸; 72.7%、その他12
.4%のIll ++ツ製脂肪故77.4gを得た。結
晶側より実施例1と同11シこ処理し、イソCl410
(イソミリスチン酸);66.2%、イソC+s+o
i 23.5%、C1n+z i 2.3%、アラ
キドン酸;4.0%、その他4.0%の高濃度イソミリ
スチン酸含有脂肪酸42.5gを得た。Example 2 Satoshi obtained in the same manner as Example 1! 245 g was hydrolyzed in a conventional manner with aqueous methanol-potassium hydroxide solution, converted back to fatty acid with hydrochloric acid water, and extracted with hexane to obtain 1913 g of a fatty acid mixture. A urea addition reaction was carried out in the same manner as in Example 1, and from the filtrate side, isoC1410 (isomyristin i; 6.1%, isoC13,.; 4.3
%, C+a+s; 3.5%, C2゜+:+i
1.0%, arachidonic acid; 72.7%, other 12
.. 77.4 g of 4% Ill++ fat residue was obtained. From the crystal side, the same treatment as in Example 1 was carried out, and the isoCl410
(isomyristic acid); 66.2%, isoC+s+o
42.5 g of high-concentration isomyristic acid-containing fatty acid containing i 23.5%, C1n+z i 2.3%, arachidonic acid: 4.0%, and other 4.0% was obtained.
次いで72.7%のアラキドン酸を含む脂肪酸77.4
t:をIlF’−20(三菱化成製)4βの入った内径
10 canのカラム上部に吸着させた。カラム上部よ
りチー1.トン/水=7/3の混合溶剤を通過させ、カ
ラム下部よりアラキドン酸含量99%以上のものを集め
、jノT痛し、37.4.のアラキドン酸99%脂肪酸
を17だ。followed by fatty acids 77.4 containing 72.7% arachidonic acid;
t: was adsorbed onto the upper part of a column with an inner diameter of 10 can containing IIF'-20 (manufactured by Mitsubishi Kasei) 4β. Chee 1 from the top of the column. A mixed solvent of 7/3 ton/water is passed through, and arachidonic acid containing 99% or more is collected from the bottom of the column, and then 37.4. Arachidonic acid 99% fatty acid is 17.
実施例3 実施例1と同様にしてメチルエステル218gを得た。Example 3 218 g of methyl ester was obtained in the same manner as in Example 1.
このメチルエステルを実施例1と同様に尿素付加反応を
行い、濾液よりイソCI 4 +。:5.3%、・イ
ソ C+s+o; 4.9 %、 C+n+*
i 3.0 %、 Czo+z;1.0%、ア
ラキドン酸;76.1%、その+l!19.79石のt
lljn製メチルエステル81.3 gを得た。結晶側
より実施例1と同様に処理し、イソC14,。; 65
.6%、イソC+s+o i 22.2%、CI8+Z
i 2.4%、アラキドン酸;3.3%、その他6.
5%の高濃度インミリスチン酸含有メチルエステル48
.8gを得た。This methyl ester was subjected to a urea addition reaction in the same manner as in Example 1, and the filtrate was extracted with isoCI 4 +. :5.3%,・i
So C+s+o; 4.9%, C+n+*
i 3.0%, Czo+z; 1.0%, arachidonic acid; 76.1%, its +l! 19.79 koku t
81.3 g of methyl ester manufactured by lljn was obtained. IsoC14 was treated in the same manner as in Example 1 from the crystal side. ; 65
.. 6%, isoC+s+o i 22.2%, CI8+Z
i 2.4%, arachidonic acid; 3.3%, others 6.
5% high concentration imiristic acid containing methyl ester 48
.. 8g was obtained.
次いで76.1%のアラキドン酸を含むメチルエステル
81.3 gをT(P−20(三菱化成製)41の入っ
た内径10cm0力ラム上部に吸着させた。カラム上部
よりメタノール/水=9/1の混合溶剤を通過させ、カ
ラム下部よりアラキドン酸含量99%以上のものを集め
、濃縮し、28.8 gのアラキドン酸99%メチルエ
ステルを得た。Next, 81.3 g of methyl ester containing 76.1% arachidonic acid was adsorbed onto the top of a 10 cm zero force column containing T (P-20 (manufactured by Mitsubishi Kasei) 41. From the top of the column, methanol/water = 9/ A mixed solvent of 1 was passed through the column, and arachidonic acid containing 99% or more was collected from the bottom of the column and concentrated to obtain 28.8 g of arachidonic acid 99% methyl ester.
又、高濃度イソミリスチン酸含有メチルエステル48.
8 gを減圧下精留することにより、イソミリスチン酸
91.2%、イソC12,。;8.8%のメチルエステ
ル22.8gを得た。Also, high concentration isomyristic acid-containing methyl ester 48.
By rectifying 8 g under reduced pressure, 91.2% of isomyristic acid, isoC12, was obtained. 22.8 g of 8.8% methyl ester were obtained.
Claims (6)
s¥ sp.)糸状菌を培養して得られるアラキドン酸
およびイソミリスチン酸含有脂質を、加水分解し、得ら
れた脂肪酸を尿素付加反応させ、一方では非尿素付加物
より粗精製されたアラキドン酸を回収し、次いで非極性
多孔性樹脂により精製してアラキドン酸を得、他方では
尿素付加物よりイソミリスチン酸を得ることを特徴とす
るアラキドン酸およびイソミリスチン酸の分離濃縮方法
。(1) Genus Conidiobolus
s¥ sp. ) Arachidonic acid and isomyristic acid-containing lipids obtained by culturing filamentous fungi are hydrolyzed, the resulting fatty acids are subjected to a urea addition reaction, and on the other hand, crudely purified arachidonic acid is recovered from the non-urea adduct; A method for separating and concentrating arachidonic acid and isomyristic acid, which is characterized in that arachidonic acid is then purified using a non-polar porous resin, and on the other hand, isomyristic acid is obtained from a urea adduct.
共重合体である特許請求の範囲第1項記載のアラキドン
酸およびイソミリスチン酸の分離濃縮方法。(2) The method for separating and concentrating arachidonic acid and isomyristic acid according to claim 1, wherein the non-polar porous resin is a styrene-divinylbenzene copolymer.
して、アセトン−水系溶剤又は低級アルコール−水系溶
剤を用いる特許請求の範囲第1項又は第2項記載のアラ
キドン酸およびイソミリスチン酸の分離濃縮方法。(3) Separation and concentration of arachidonic acid and isomyristic acid according to claim 1 or 2 using an acetone-water solvent or a lower alcohol-water solvent as an eluent in purification using a non-polar porous resin. Method.
s¥ sp.)糸状菌を培養して得られるアラキドン酸
およびイソミリスチン酸含有脂質を、低級アルコールと
アルコーリシスし、得られた脂肪酸低級アルコールエス
テルを尿素付加反応させ、一方では非尿素付加物より粗
精製されたアラキドン酸低級アルコールエステルを回収
し、次いで非極性多孔性樹脂により精製してアラキドン
酸低級アルコールエステルを得、他方では尿素付加物よ
りイソミリスチン酸低級アルコールエステルを得ること
を特徴とするアラキドン酸およびイソミリスチン酸の分
離濃縮方法。(4) Genus Conidiobolus (¥Conidiobolu
s¥ sp. ) Lipids containing arachidonic acid and isomyristic acid obtained by culturing filamentous fungi are subjected to alcoholysis with lower alcohols, and the resulting fatty acid lower alcohol esters are subjected to urea addition reaction, while crudely purified from non-urea adducts. Arachidonic acid and isomyritic acid lower alcohol ester is recovered and then purified by a non-polar porous resin to obtain arachidonic acid lower alcohol ester, and on the other hand, isomyristic acid lower alcohol ester is obtained from the urea adduct. Method for separating and concentrating myristic acid.
共重合体である特許請求の範囲第4項記載のアラキドン
酸およびイソミリスチン酸の分離濃縮方法。(5) The method for separating and concentrating arachidonic acid and isomyristic acid according to claim 4, wherein the non-polar porous resin is a styrene-divinylbenzene copolymer.
して、アセトン−水系溶剤又は低級アルコール−水系溶
剤を用いる特許請求の範囲第4項又は第5項記載のアラ
キドン酸およびイソミリスチン酸の分離濃縮方法。(6) Separation and concentration of arachidonic acid and isomyristic acid according to claim 4 or 5, using an acetone-water solvent or a lower alcohol-water solvent as an eluent in purification using a non-polar porous resin. Method.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61256951A JPS63112694A (en) | 1986-10-30 | 1986-10-30 | Separation and concentration of arachidonic acid and isomyristic acid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61256951A JPS63112694A (en) | 1986-10-30 | 1986-10-30 | Separation and concentration of arachidonic acid and isomyristic acid |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS63112694A true JPS63112694A (en) | 1988-05-17 |
Family
ID=17299627
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP61256951A Pending JPS63112694A (en) | 1986-10-30 | 1986-10-30 | Separation and concentration of arachidonic acid and isomyristic acid |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS63112694A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991008676A1 (en) * | 1989-12-18 | 1991-06-27 | Kraft General Foods, Inc. | Low-saturate edible oils and transesterification methods for production thereof |
JP2020529397A (en) * | 2017-08-07 | 2020-10-08 | ディーエスエム アイピー アセッツ ビー.ブイ.Dsm Ip Assets B.V. | Manufacturing process of concentrated polyunsaturated fatty acid oil |
CN112375008A (en) * | 2020-11-24 | 2021-02-19 | 江苏恒正合生命科学有限公司 | Synthesis and purification method of arachidonic acid ethanolamine |
-
1986
- 1986-10-30 JP JP61256951A patent/JPS63112694A/en active Pending
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991008676A1 (en) * | 1989-12-18 | 1991-06-27 | Kraft General Foods, Inc. | Low-saturate edible oils and transesterification methods for production thereof |
JP2020529397A (en) * | 2017-08-07 | 2020-10-08 | ディーエスエム アイピー アセッツ ビー.ブイ.Dsm Ip Assets B.V. | Manufacturing process of concentrated polyunsaturated fatty acid oil |
CN112375008A (en) * | 2020-11-24 | 2021-02-19 | 江苏恒正合生命科学有限公司 | Synthesis and purification method of arachidonic acid ethanolamine |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2462417A1 (en) | NOVEL MONACOLIN K DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC APPLICATION | |
JPH0365948B2 (en) | ||
JPS63112694A (en) | Separation and concentration of arachidonic acid and isomyristic acid | |
JP5530696B2 (en) | Plasmalogen phospholipid | |
JP2730081B2 (en) | Method for producing arachidonic acid-containing fats and oils by microorganism | |
US3956337A (en) | Process for the preparation of D-gluconic-δ-lactam | |
FR2518546A1 (en) | DIHYDRO- AND TETRAHYDROMONACOLINES, THEIR PREPARATION METHOD AND THEIR THERAPEUTIC APPLICATION | |
FR2492664A1 (en) | B-GALACTOSIDASE INHIBITOR, SAID GT-2558, AND DERIVATIVES THEREOF FOR USE AS CANCERISTATICS | |
JP2740854B2 (en) | Process for producing dihomo-γ-linolenic acid and inhibitor for fatty acid Δ5 desaturation reaction | |
JPS58201736A (en) | Preparation of polyprenol | |
JPS63295527A (en) | Method for concentrating and separating highly unsaturated fatty acid | |
JPH0216989A (en) | Production of omega6-based unsaturated fatty acid-containing phospholipid | |
JPS63216490A (en) | Production of eicosapentaenoic acid by microorganism and microorganism using therefor | |
JPS63102688A (en) | Production of arachidonic acid-containing fats and oils | |
CA2123587A1 (en) | Bactericide product; pharmaceutical composition and food additive containing the same | |
JPS639838B2 (en) | ||
BE526313A (en) | ||
BE865590A (en) | ANTIBIOTIC COMPOSITIONS AND THEIR USE | |
JPS63251099A (en) | Production of (+)-trans-(1r, 3r)-2,2-dimethyl-3(2,2-dichlorovinyl) cyclopropane carboxylic acid | |
JPS6034550B2 (en) | Enzyme inhibitor KM-2753 and its production method | |
JPH03271284A (en) | New compound folipastatin | |
FR2524886A1 (en) | ||
BE1003486A5 (en) | Production method for an influenza virus neuraminidase inhibitor | |
JPH0631280B2 (en) | WS7739 substance and its manufacturing method | |
JPS63216488A (en) | Production of eicosapentaenoic acid by microorganism and microorganism using therefor |